Literature DB >> 24192668

Gentamicin concentration gradients in scala tympani perilymph following systemic applications.

Hartmut Hahn1, Alec N Salt, Ulrike Schumacher, Stefan K Plontke.   

Abstract

It has been shown in prior studies that round window membrane (RWM) application of gentamicin produced a robust basal-apical concentration gradient in the perilymph of scala tympani (ST) with peak concentrations in the basal turn of ST. These gradients potentially contribute to the clinical efficacy and safety of intratympanic gentamicin applications for the treatment of Ménière's disease. The present study aimed to establish the distribution of gentamicin along ST perilymph after systemic applications. Gentamicin sulfate was applied intravenously in the amounts of 100, 300 and 600 mg/kg body weight (BW) over a period of 3 h or as a 300 mg/kg BW subcutaneous bolus injection. At 3 and 5 h after the start of the application perilymph of ST was aspirated from the cochlea apex of the right and left cochlea, respectively, and 10 sequential 1-µl perilymph samples from the apex of each cochlea were quantitatively analyzed using a fluorescence polarization immunoassay. In contrast to local RWM delivery, systemic application of gentamicin resulted in the highest perilymph levels in the apex of the cochlea with decreasing concentrations towards the basal regions of ST. The absolute gentamicin concentrations increased with the amount of drug applied and time before sampling. While it is likely that the basal-apical gradient measured after local drug applications to the round window niche is the result of the direct uptake of drugs into the perilymph of the ST, distribution by diffusion and a very low perilymph flow towards the cochlear apex, computer simulations suggested that the apical-basal gradient observed with these systemic applications can be explained by higher entry rates of gentamicin in the apex compared to the basal turns of the cochlea. It is also possible that gentamicin enters perilymph indirectly from the blood via the endolymph. In this case the faster kinetics in apical turns could be due to the smaller cross-sectional area of ST relative to endolymph in the apical turns.
© 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24192668      PMCID: PMC3918439          DOI: 10.1159/000355283

Source DB:  PubMed          Journal:  Audiol Neurootol        ISSN: 1420-3030            Impact factor:   1.854


  36 in total

1.  Differential vulnerability of basal and apical hair cells is based on intrinsic susceptibility to free radicals.

Authors:  S H Sha; R Taylor; A Forge; J Schacht
Journal:  Hear Res       Date:  2001-05       Impact factor: 3.208

2.  Tonotopic variation in the conductance of the hair cell mechanotransducer channel.

Authors:  Anthony J Ricci; Andrew C Crawford; Robert Fettiplace
Journal:  Neuron       Date:  2003-12-04       Impact factor: 17.173

3.  Intratympanic gentamicin therapy for Ménière's disease: a meta-analysis.

Authors:  Stanley H Chia; Anthony C Gamst; John P Anderson; Jeffrey P Harris
Journal:  Otol Neurotol       Date:  2004-07       Impact factor: 2.311

4.  Distribution of gentamicin in the guinea pig inner ear after local or systemic application.

Authors:  Shun-Ichi Imamura; Joe C Adams
Journal:  J Assoc Res Otolaryngol       Date:  2003-06

5.  Experimental ototoxicity of gentamicin in squirrel monkeys.

Authors:  M Igarashi; P G Lundquist; B R Alford; H Miyata
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

6.  Analysis of gentamicin kinetics in fluids of the inner ear with round window administration.

Authors:  Stefan K R Plontke; Arthur W Wood; Alec N Salt
Journal:  Otol Neurotol       Date:  2002-11       Impact factor: 2.311

7.  Surface microstructure of the perilymphatic space: implications for cochlear implants and cell- or drug-based therapies.

Authors:  Robert K Shepherd; Michael P Colreavy
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2004-05

8.  10 years of experience with intratympanally applied streptomycin (gentamycin) in the therapy of Morbus Menière.

Authors:  C Beck; C L Schmidt
Journal:  Arch Otorhinolaryngol       Date:  1978-09-28

9.  [The intratympanic treatment of Menière's disease with ototoxic antibiotics. A follow-up study of 55 cases (author's transl)].

Authors:  G Lange
Journal:  Laryngol Rhinol Otol (Stuttg)       Date:  1977-05

10.  Integrity and regeneration of mechanotransduction machinery regulate aminoglycoside entry and sensory cell death.

Authors:  Andrew A Vu; Garani S Nadaraja; Markus E Huth; Lauren Luk; John Kim; Renjie Chai; Anthony J Ricci; Alan G Cheng
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

View more
  10 in total

1.  Systemic lipopolysaccharide compromises the blood-labyrinth barrier and increases entry of serum fluorescein into the perilymph.

Authors:  Keiko Hirose; Jared J Hartsock; Shane Johnson; Peter Santi; Alec N Salt
Journal:  J Assoc Res Otolaryngol       Date:  2014-06-21

2.  Hearing Changes After Intratympanically Applied Steroids for Primary Therapy of Sudden Hearing Loss: A Meta-analysis Using Mathematical Simulations of Drug Delivery Protocols.

Authors:  Arne Liebau; Olivia Pogorzelski; Alec N Salt; Stefan K Plontke
Journal:  Otol Neurotol       Date:  2017-01       Impact factor: 2.311

Review 3.  Communication pathways to and from the inner ear and their contributions to drug delivery.

Authors:  Alec N Salt; Keiko Hirose
Journal:  Hear Res       Date:  2017-12-19       Impact factor: 3.208

4.  Perilymph pharmacokinetics of locally-applied gentamicin in the guinea pig.

Authors:  A N Salt; J J Hartsock; R M Gill; E King; F B Kraus; S K Plontke
Journal:  Hear Res       Date:  2016-10-08       Impact factor: 3.208

5.  Uncoiling the Human Cochlea-Physical Scala Tympani Models to Study Pharmacokinetics Inside the Inner Ear.

Authors:  Daniel Schurzig; Max Fröhlich; Stefan Raggl; Verena Scheper; Thomas Lenarz; Thomas S Rau
Journal:  Life (Basel)       Date:  2021-04-21

6.  CT imaging of the Eustachian tube using focal contrast medium administration: a feasibility study in humans.

Authors:  Benedicte Falkenberg-Jensen; Greg E Jablonski; Juha T Silvola; Joanna F Kristiansen; Einar Hopp
Journal:  Acta Radiol Open       Date:  2020-01-22

7.  ASK1 is a novel molecular target for preventing aminoglycoside-induced hair cell death.

Authors:  Jacqueline M Ogier; Yujing Gao; Eileen M Dunne; Michael A Wilson; Sarath C Ranganathan; Gregory H Tesch; David J Nikolic Paterson; Alain Dabdoub; Rachel A Burt; Bryony A Nayagam; Paul J Lockhart
Journal:  J Mol Med (Berl)       Date:  2022-04-26       Impact factor: 5.606

Review 8.  Use of the guinea pig in studies on the development and prevention of acquired sensorineural hearing loss, with an emphasis on noise.

Authors:  Gaëlle Naert; Marie-Pierre Pasdelou; Colleen G Le Prell
Journal:  J Acoust Soc Am       Date:  2019-11       Impact factor: 2.482

9.  In vitro gentamicin exposure alters caveolae protein profile in cochlear spiral ligament pericytes.

Authors:  Elisa Ghelfi; Yohann Grondin; Emil J Millet; Adam Bartos; Magda Bortoni; Clara Oliveira Gomes Dos Santos; Humberto J Trevino-Villarreal; Rosalinda Sepulveda; Rick Rogers
Journal:  Proteome Sci       Date:  2018-03-16       Impact factor: 2.480

10.  Effects of Glycemic Control on Hearing Outcomes in Diabetes Patients With Idiopathic Sudden Sensorineural Hearing Loss.

Authors:  Euyhyun Park; Jaehyun Shim; Soo Jeong Choi; Hak Hyun Jung; Gi Jung Im
Journal:  J Int Adv Otol       Date:  2021-03       Impact factor: 1.316

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.